Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
TransCode Therapeutics, Inc.
Market Cap
$1.88M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.88M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.84M
Net Profit Margin
-256.33%
TTM Avg
-367.80%
3Y Avg
-1001.34%
5Y Avg
-1624.30%
Market Cap
$1.84M
Net Profit Margin
-435.71%
TTM Avg
-845.71%
3Y Avg
-1722.30%
5Y Avg
-1584.91%
Market Cap
$1.83M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.81M
Net Profit Margin
-133666.67%
TTM Avg
-65155.00%
3Y Avg
-208600.31%
5Y Avg
-142364.65%
Market Cap
$2.13M
Net Profit Margin
-862.34%
TTM Avg
-747.16%
3Y Avg
-4673.17%
5Y Avg
-3945.34%
Market Cap
$1.64M
Net Profit Margin
-8269.53%
TTM Avg
-5978.05%
3Y Avg
-5627.38%
5Y Avg
-2838.61%
Market Cap
$2.14M
Net Profit Margin
-122.42%
TTM Avg
-97.90%
3Y Avg
-110.76%
5Y Avg
-109.24%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TransCode Therapeutics, Inc. (RNAZ) | $1.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tenon Medical, Inc. (TNON)vs › | $1.84M | -256.33% | -367.80% | -1001.34% | -1624.30% |
| Beyond Air, Inc. (XAIR)vs › | $1.84M | -435.71% | -845.71% | -1722.30% | -1584.91% |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.83M | 0.00% | 0.00% | 0.00% | 0.00% |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.81M | -133666.67% | -65155.00% | -208600.31% | -142364.65% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | -862.34% | -747.16% | -4673.17% | -3945.34% |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | -8269.53% | -5978.05% | -5627.38% | -2838.61% |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | -122.42% | -97.90% | -110.76% | -109.24% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
